News | Subscribe | My Account | About Us | Contact Us | Repertoire Home
May 23, 2017

From the Publisher

  • Retrain the Marketing Brain
  • From ANAE

  • Dont miss out on face-to-face time with your customers at the ANAE Annual Conference in Marina del Rey, CA July 10-11, 2017!
  • Manufacturer News

  • bioMérieux supporting the launch of the AMR Industry Alliance
  • Hill-Rom Introduces Envella Air Fluidized Therapy Bed
  • Integra LifeSciences announces agreement with aap to distribute LOQTEQ Distal Radius System in US
  • Sanofi and Regeneron receive FDA approval of Kevzara for treatment of moderately to severely active rheumatoid arthritis in adult patients
  • Hospital and IDN News

  • Vital baking soda shortage forces hospitals to postpone surgeries, treatments
  • CHS rejects physicians' $2.4B offer for Lutheran Health Network
  • Stock Watch

  • Health Stocks
  • From the Publisher
    Retrain the Marketing Brain
    Susan Robertson will speak at Share Moving Media’s inaugural “Strategic Marketing Summit,” which will be held July 26-27, 2017 in Atlanta, Georgia. Robertson will speak on retraining your brain. This session will help you and your team be more engaged in your work, more innovative in your approaches, and better able to consistently perform at your highest.

    Share Moving Media is excited to show you how your organization can deploy best-in-class content to attract the IDN, RPC, and distributor partners you need for success. The meeting will feature experts across multiple disciplines, who will show you how to create an experience through content – in order to help you achieve your goals this year!

    Who should attend?
    • CMOs
    • Vice Presidents of Marketing
    • Directors of Marketing
    • Product Managers
    • Channel Managers


    Space is limited! Click here to register and view the full agenda.
    -back to top-
    From ANAE
    Dont miss out on face-to-face time with your customers at the ANAE Annual Conference in Marina del Rey, CA July 10-11, 2017!
    The ANAE Annual Conference will be held July 10-11, 2017 in Marina del Rey, California. The ANAE Annual Conference is an opportunity for ANAE members and prospective members to network with their peers and customers and hear from leading supply chain executives on how to work successfully with IDNs. Attendees will also be able to attend a personal and professional development session on the indispensable art of selling with Dianne Watts, CEO of Watts Professional Development.

    Confirmed Speakers:
    -- Lisa Thakur, VP operations, Scripps Health
    -- Jerry Dea, executive director supply chain, Cedars-Sinai Health System
    -- Kevin Thompson, chief supply chain officer, Sharp Healthcare System
    -- Justin Freed, AVP CA region supply chain, Providence St. Joseph Health System
    -- Dan Neufelder, former CEO, Ministry Health, currently CEO, Neufelder Consulting Group LLC
    -- Diane Watts, CEO, Watts Professional Development
    -- Rebecca Morrill, senior director, development member business ventures, Vizient Inc
    -- Shaun Clinton, senior vice president supply chain, Texas Health Resources Catholic Contracting Group
    -- J.R. Kyle, director of sourcing integration, BJC Healthcare Mid-America Service Solution LLC
    -- Kim Moon, director of supply chain, Tucson Medical, Vizient’s West Coast Purchasing Coalition
    -- And more to come!

    Click here for more information and to register.

    Questions? Contact Anna McCormick at amccormick@sharemovingmedia.com.
    -back to top-
    Manufacturer News
    bioMérieux supporting the launch of the AMR Industry Alliance
    bioMérieux (Marcy l'Etoile, France) announced its support for the launch of the AMR Industry Alliance, a new alliance to drive and measure industry progress to curb antimicrobial resistance. bioMérieux chief medical officer Mark Miller will serve on the Alliance board, representing the diagnostic industry along with Andrew Fish, executive director, AdvaMedDx. bioMérieux has been a pioneer in the diagnosis of infectious diseases and is a strong advocate of the fight against resistance. Most recently, bioMérieux signed the Industry Declaration on AMR at World Economic Forum in Davos. To learn more about the AMR Industry Alliance, read their latest press release.
    -back to top-
    Hill-Rom Introduces Envella Air Fluidized Therapy Bed
    Hill-Rom Holdings Inc (Chicago, IL) unveiled the new Hill-Rom Envella Air Fluidized Therapy Bed. In designing the Envella bed, Hill-Rom pursued the singular goal of elevating the standard of wound care, designing every aspect of the bedframe and therapeutic surface to drive superior outcomes and a higher quality of care for a broader range of complex patients. From increased bead depth, adjustable air flow and sensing technologies, to advanced weight-based pressure distribution and an integrated scale, the Envella bed is designed to make air fluidized therapy (AFT) more comfortable and safer for patients, and easier for caregivers to use.
    -back to top-
    Integra LifeSciences announces agreement with aap to distribute LOQTEQ Distal Radius System in US
    Integra LifeSciences Holdings Corporation (Plainsboro, NJ) signed an agreement with aap Implantate AG (Berlin, Germany) to distribute the LOQTEQ Distal Radius System within the U.S. aap is a globally operating medical device company developing, manufacturing and marking trauma products for orthopedics. The LOQTEQ distal radius system features state-of-the-art designs with multiple plate options to accommodate a variety of fracture patterns and anatomies, as well as instrumentation designed for intra-operative efficiency.
    -back to top-
    Sanofi and Regeneron receive FDA approval of Kevzara for treatment of moderately to severely active rheumatoid arthritis in adult patients
    Sanofi (Paris, France) and Regeneron Pharmaceuticals Inc (Tarrytown, NY) received FDA approval for Kevzara (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX) Kevzara is a human monoclonal antibody that binds to the interleukin-6 receptor (IL-6R), and has been shown to inhibit IL-6R mediated signaling. IL-6 is a cytokine in the body that, in excess and over time, can contribute to the inflammation associated with RA. Click here to learn more.
    -back to top-
    Hospital and IDN News
    Vital baking soda shortage forces hospitals to postpone surgeries, treatments
    U.S. hospitals are scrambling to stockpile vials of a critical drug — even postponing operations or putting off chemotherapy treatments due to a major shortage of sodium bicarbonate solution. The shortage is the result of the country’s only two suppliers running out of the drug. Hospitals have been struggling with a dwindling supply of the medicine for months — one of the suppliers, Pfizer, has said that it had a problem with an outside supplier but that the situation worsened a few weeks ago. Pfizer and the other manufacturer, Amphastar, have said they don’t know precisely when the problem will be fixed, but it will not be before June for some forms of the drug, and in August or later for other formulations, according to the New York Times. Sodium bicarbonate solution — which contains baking soda as a base ingredient — is used for open heart surgery, some forms of chemotherapy and as a treatment when a patient's blood is too acidic. The drug, often stashed on emergency crash carts, also serves as an antidote to some poisons and as a treatment for patients whose organs are failing. Click here to read more.
    -back to top-
    CHS rejects physicians' $2.4B offer for Lutheran Health Network
    Community Health Systems (Franklin, TN) refused a local physician group's offer to purchase Lutheran Health Network (Fort Wayne, IN), an eight-hospital system. CHS said the group "failed to satisfy any reasonable criteria of a legitimate offer.” The group submitted a proposal May 18 to purchase LHN for $2.4 billion. CHS officials had until 12 p.m. Monday to accept or reject the offer. More than 100 physicians, medical staff and 17 area members of the Indiana Legislature issued their support for the sale. The physician group said it decided to submit an offer because it no longer believed CHS would "make decisions that are in the best interest of [their] patients, staff and community." Minutes before the deadline, for-profit CHS notified the group that "it does not intend to have further discussions about a potential sale."
    -back to top-
    Stock Watch
    Health Stocks

    Quotes last updated at 5/22/2017 4:12:28 PM EST

    SymbolCompanyPriceChangeTrends
    MMM3M COMPANY198.51+2.71Analyze
    ABTABBOTT LABS43.76+0.60Analyze
    ABBVABBVIE INC65.41-0.17Analyze
    ALRALERE INC48.62+1.14Analyze
    ABCAMERISOURCEBERGN89.55+0.39Analyze
    BAXBAXTER INTL INC57.71+0.50Analyze
    BDXBECTON DICKINSON184.88+0.75Analyze
    BSXBOSTON SCIENTIFIC26.785+0.375Analyze
    BVXBOVIE MEDICAL CORP2.06-0.09Analyze
    BMYBRISTOL MYERS SQ54.14+0.12Analyze
    CMNCANTEL MEDICAL81.14+0.00Analyze
    CAHCARDINAL HEALTH73.235-0.265Analyze
    CPHDCEPHEID52.95+0.00Analyze
    CERNCERNER CORP64.60+0.50Analyze
    CLXCLOROX132.68+0.52Analyze
    CNMDCONMED CORP49.99+0.27Analyze
    BCRCR BARD INC307.37-0.18Analyze
    CRYCRYOLIFE18.30+0.05Analyze
    DHRDANAHER82.98+0.84Analyze
    DVCRDIVERSICARE HEALTHCARE SERVICES11.19+0.00Analyze
    DYIIDYNACQ HEALTHCARE0.05+0.00Analyze
    ESRXEXPRESS SCRIPTS60.28+0.17Analyze
    GEGENERAL ELECTRIC COMPANY28.17+0.12Analyze
    HCAHCA82.35+0.20Analyze
    HSTMHEALTHSTREAM INC28.64+0.11Analyze
    HSICHENRY SCHEIN180.85+3.04Analyze
    HRCHILL-ROM HOLDINGS INC75.485+0.655Analyze
    HMSYHMS HOLDINGS18.12+0.14Analyze
    HOLXHOLOGIC INC43.19+0.19Analyze
    ICUIICU MEDICAL162.15-1.00Analyze
    IARTINTEGRA LIFESCIENCES HOLDINGS CORP48.00+0.61Analyze
    JNJJOHNSON & JOHNSON127.27+0.27Analyze
    MASIMASIMO CORP85.99+0.32Analyze
    MCKMCKESSON CORP155.53+2.52Analyze
    MDASMEDASSETS31.35+0.00Analyze
    MDTMEDTRONIC INC84.095+0.865Analyze
    MMSIMERIT MEDICAL SYSTEMS34.00+0.45Analyze
    MSFTMICROSOFT68.435+0.745Analyze
    MDXGMIMEDX GROUP INC14.34+0.08Analyze
    MYLMYLAN LABS38.715+0.775Analyze
    ^IXICNASDAQ Composite6133.62+49.92Analyze
    OMCLOMNICELL41.35+0.40Analyze
    OMIOWENS & MINOR32.03-0.15Analyze
    PHGPHILIPS35.73+0.23Analyze
    PINCPREMIER INC34.53-0.07Analyze
    QDELQUIDEL CORP24.59+0.18Analyze
    ^GSPCS&P 500 Index2394.02+12.29Analyze
    SNNSMITH & NEPHEW34.90+0.17Analyze
    SWKSTANLEY BLACK & DECKER INC136.32-0.23Analyze
    STESTERIS CORP75.94+0.36Analyze
    SYKSTRYKER CORP138.725+1.915Analyze
    SGCSUPERIOR UNIFORM GROUP18.61+0.78Analyze
    TFXTELEFLEX MEDICAL198.91+2.32Analyze
    TMOTHERMO FISHER SCI172.26+0.73Analyze
    ZMHZIMMER HOLDINGS113.56+0.00Analyze
    -back to top-


    Copyright © , MDSI. All Rights Reserved.
    Privacy Policy